Enhancing compliance to increase cost effectiveness

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.369, 2002-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost effectiveness of risperidone: is compliance the key?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Balancing cost effectiveness and innovation

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 531, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost effectiveness of ixabepilone debated

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics

By Phillips Kathryn A Veenstra David Bebber Stephanie Van Sakowski Julie

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 231-239

Future Medicine

Access to resources Recommend Favorite